Based on a new mechanism of action, we performed an in-depth survey of the TCGA database for genomic and RNA expression features that promote anti-CTLA-4 response, including target (CTLA-4) expression, gene signature, immune cell composition, tumor mutation burden, and ADCC/ADCP features. Here, CTLA4 is linked to neoplasm.